CRY Cryolife Inc

Price (delayed)

$29.58

Market cap

$1.16B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$1.45B

Highlights
CRY's EPS is up by 20% since the previous quarter
The net income has plunged by 183% YoY but it has grown by 21% from the previous quarter
CRY's equity is down by 10% since the previous quarter but it is up by 7% year-on-year
The debt has grown by 31% YoY and by 13% from the previous quarter
CRY's quick ratio is down by 30% year-on-year

Key stats

What are the main financial stats of CRY
Market
Shares outstanding
39.1M
Market cap
$1.16B
Enterprise value
$1.45B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.88
Price to sales (P/S)
4.44
EV/EBIT
380.89
EV/EBITDA
42.02
EV/Sales
5.63
Earnings
Revenue
$257.89M
EBIT
$3.81M
EBITDA
$34.53M
Free cash flow
$404,000
Per share
EPS
-$0.35
Free cash flow per share
$0.01
Book value per share
$7.63
Revenue per share
$6.66
TBVPS
$8.33
Balance sheet
Total assets
$794.83M
Total liabilities
$497.5M
Debt
$351.22M
Equity
$297.33M
Working capital
$177.67M
Liquidity
Debt to equity
1.18
Current ratio
4.06
Quick ratio
1.86
Net debt/EBITDA
8.53
Margins
EBITDA margin
13.4%
Gross margin
66.5%
Net margin
-5.1%
Operating margin
2%
Efficiency
Return on assets
-1.7%
Return on equity
-4.2%
Return on invested capital
0.7%
Return on capital employed
0.5%
Return on sales
1.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRY stock price

How has the Cryolife stock price performed over time
Intraday
0%
1 week
2.82%
1 month
2.04%
1 year
25.93%
YTD
25.29%
QTD
31%

Financial performance

How have Cryolife's revenue and profit performed over time
Revenue
$257.89M
Gross profit
$171.45M
Operating income
$5.07M
Net income
-$13.16M
Gross margin
66.5%
Net margin
-5.1%
The net margin has plunged by 200% YoY but it has grown by 23% from the previous quarter
The net income has plunged by 183% YoY but it has grown by 21% from the previous quarter
The operating income has soared by 108% QoQ but it has shrunk by 63% YoY
Cryolife's operating margin has surged by 100% QoQ but it has shrunk by 60% YoY

Growth

What is Cryolife's growth rate over time

Valuation

What is Cryolife stock price valuation
P/E
N/A
P/B
3.88
P/S
4.44
EV/EBIT
380.89
EV/EBITDA
42.02
EV/Sales
5.63
CRY's EPS is up by 20% since the previous quarter
CRY's P/B is 49% more than its last 4 quarters average of 2.6 and 25% more than its 5-year quarterly average of 3.1
CRY's equity is down by 10% since the previous quarter but it is up by 7% year-on-year
CRY's P/S is 43% higher than its last 4 quarters average of 3.1 and 27% higher than its 5-year quarterly average of 3.5
The revenue fell by 6% YoY

Efficiency

How efficient is Cryolife business performance
Cryolife's return on equity has shrunk by 147% YoY but it has increased by 22% QoQ
The ROA has dropped by 113% year-on-year but it has increased by 26% since the previous quarter
The ROIC has dropped by 68% year-on-year
CRY's ROS has dropped by 57% year-on-year

Dividends

What is CRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRY.

Financial health

How did Cryolife financials performed over time
The total assets is 60% more than the total liabilities
Cryolife's total liabilities has increased by 44% YoY and by 8% QoQ
CRY's quick ratio is down by 30% year-on-year
The debt is 18% more than the equity
The debt has grown by 31% YoY and by 13% from the previous quarter
The debt to equity has grown by 24% from the previous quarter and by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.